| 2nd May 2019 5:20 pm |
RNS |
Statement regarding Price Movement |
| 2nd May 2019 2:05 pm |
RNS |
Second Price Monitoring Extn |
| 2nd May 2019 2:00 pm |
RNS |
Price Monitoring Extension |
| 29th Apr 2019 7:00 am |
RNS |
Results from the Japanese Phase III study |
| 25th Apr 2019 4:09 pm |
RNS |
Holding(s) in Company |
| 12th Apr 2019 1:20 pm |
RNS |
Holding(s) in Company |
| 11th Apr 2019 7:00 am |
RNS |
First expansion cohort for MATINS trial part 2 |
| 10th Apr 2019 11:41 am |
RNS |
Holding(s) in Company |
| 5th Apr 2019 7:00 am |
RNS |
Notice of Results |
| 2nd Apr 2019 9:23 am |
RNS |
Holdings in Company |
| 29th Mar 2019 7:00 am |
RNS |
Holding(s) in Company |
| 28th Mar 2019 12:54 pm |
RNS |
Results of the Placing and Subscription |
| 26th Mar 2019 3:31 pm |
RNS |
Result of Placing and Issue Price |
| 26th Mar 2019 7:00 am |
RNS |
Proposed Placing to raise approximately EUR 3m |
| 21st Feb 2019 7:00 am |
RNS |
MATINS study update |
| 13th Feb 2019 8:57 am |
RNS |
New data published by Clinical Cancer Research |
| 19th Dec 2018 7:00 am |
RNS |
Traumakine update - YODA results |
| 14th Dec 2018 11:20 am |
RNS |
First patient dosed in phase I/II MATINS study |
| 11th Dec 2018 4:26 pm |
RNS |
Holding(s) in Company |
| 5th Dec 2018 7:00 am |
RNS |
Patient subgroup identified from INTEREST trial |
| 3rd Dec 2018 7:00 am |
RNS |
Faron receives CTA approval for Clevegen |
| 6th Nov 2018 3:52 pm |
RNS |
PDMR Dealings |
| 23rd Oct 2018 11:05 am |
RNS |
Second Price Monitoring Extn |
| 23rd Oct 2018 11:00 am |
RNS |
Price Monitoring Extension |
| 23rd Oct 2018 9:06 am |
RNS |
Second Price Monitoring Extn |
| 23rd Oct 2018 9:00 am |
RNS |
Price Monitoring Extension |
| 22nd Oct 2018 3:00 pm |
RNS |
INTEREST trial update presented at ESICM |
| 18th Sep 2018 9:23 am |
RNS |
Director/PDMR Shareholding |
| 17th Sep 2018 7:00 am |
RNS |
Faron announces CTA filing for Clevegen |
| 13th Sep 2018 7:00 am |
RNS |
Interim Results |
| 12th Sep 2018 7:00 am |
RNS |
New data published on Clever-1 function |
| 8th Aug 2018 11:05 am |
RNS |
Second Price Monitoring Extn |
| 8th Aug 2018 11:00 am |
RNS |
Price Monitoring Extension |
| 8th Aug 2018 7:00 am |
RNS |
Notice of Interim Results |
| 9th Jul 2018 8:45 am |
RNS |
Holding(s) in Company |
| 28th Jun 2018 7:00 am |
RNS |
Clevegen successful toxicity studies |
| 22nd Jun 2018 7:00 am |
RNS |
Holdings in Company |
| 21st Jun 2018 3:58 pm |
RNS |
Director/PDMR Shareholding |
| 21st Jun 2018 9:00 am |
RNS |
Price Monitoring Extension |
| 21st Jun 2018 7:40 am |
RNS |
Director/PDMR Shareholding |
